Litigation Details for FRESENIUS KABI USA, LLC. v. PAR STERILE PRODUCTS, LLC (D.N.J. 2015)
✉ Email this page to a colleague
FRESENIUS KABI USA, LLC. v. PAR STERILE PRODUCTS, LLC (D.N.J. 2015)
Docket | ⤷ Try a Trial | Date Filed | 2015-06-09 |
Court | District Court, D. New Jersey | Date Terminated | 2016-03-28 |
Cause | 35:271 Patent Infringement | Assigned To | Kevin McNulty |
Jury Demand | None | Referred To | Michael A. Hammer |
Patents | 9,006,289; 9,168,238; 9,168,239 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FRESENIUS KABI USA, LLC. v. PAR STERILE PRODUCTS, LLC
Details for FRESENIUS KABI USA, LLC. v. PAR STERILE PRODUCTS, LLC (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-07-06 | 11 | purports to be a version of U.S. Patent No. 9,006,289 (the ’289 patent), titled “Levothyroxine Formulations…the ’289 patent when it submitted its Paragraph IV certification directed to the ’289 patent. Par denies…owns the ’289 patent. 3. This is a declaratory judgment action under the patent laws of the…289 patent. 10. Par Sterile is entitled to a declaratory judgment that the ’289 patent is …289 patent. 14. Par Sterile is entitled to a declaratory judgment that the ’289 patent is | External link to document | |
2016-03-28 | 41 | that its United States Patent Nos. 9,006,289, 9,168,238, 9,168,239 (“the patents-in-suit”) are enforceable…products, that the patents-in-suit are enforceable and valid and that the patents-in-suit would be infringed…enforceable and valid and that the patents-in-suit would be infringed by the manufacture, use, sale, offer…shall be not earlier than the expiration of the patents-in-suit, unless otherwise authorized by Plaintiff…Defendants’ Products until the expiration of the patents-in-suit, except to the extent expressly permitted | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |